Hebei Changshan Biochemica – Market Overview and Recent Regulatory Update
Market Performance
- Trading Activity (Tuesday 20th, 11:29 PM CET)
- Stock traded flat (0 %) during the 24‑hour period.
- Current trading price: CNY 20.15.
- Market capitalization: CNY 18.3 bn.
- Total shares outstanding: 949.6 mn.
- Trading volume in the last 24 hours: CNY 519.9 mn.
- 52‑week high: CNY 71.71 (11/03/2025).
- 52‑week low: CNY 18.53 (10/19/2026).
- Simple moving average (200 days): CNY 27.
- Year‑to‑date performance: –20.17 % since the end of last month.
Recent Regulatory Development
Hebei Changshan Biochemica announced that its anticoagulant product, Enoxaparin sodium injection, has completed the European Union’s Dispersed Clinical Programme (DCP) assessment in Croatia. This milestone indicates progress toward broader regulatory approval across EU member states. The company notes that overseas sales constitute a modest portion of overall revenue, implying limited immediate impact on short‑term earnings. No additional operational changes or financial commitments were disclosed.
Context – Peer Performance
| Symbol | Trading Status | Current Price | Market Cap | P/E | Notes |
|---|---|---|---|---|---|
| Bestechnic Shanghai (688608.SS) | Flat | CNY 106.32 | CNY 21.9 bn | 53.35 | Technology themes, modest index movements |
| Guangzhou Great Power Ener (300438.SZ) | Flat | CNY 41.60 | CNY 21.7 bn | 19.11 | Announces acquisition of lithium‑battery electrolyte manufacturer |
| Hangzhou Ezviz Network (688475.SS) | Flat | CNY 28.40 | CNY 21.6 bn | – | Increased institutional ownership in Q3 |
| Xtalpi (2228.HK) | +0.51 % | HKD 6.09 | HKD 25.5 bn | – | Potential inclusion in Hang Seng Tech index |
| Qingdao Gon (2768.HK) | +3.05 % | HKD 33.46 | HKD 25.7 bn | 24.93 | – |
Company Profile
Hebei Changshan Biochemical Pharmaceutical Co Ltd., founded in 2000 and headquartered in Zhengding, China, specializes in the research, development, production, and sales of heparin products. Its product portfolio includes heparin sodium APIs, low‑molecular‑weight heparin calcium injections, heparin sodium injections, sodium hyaluronate, hard capsules, and Yihaitang capsule (an anti‑aging health product). The company also markets reviparin sodium, hyaluronic acid, and heparinoid APIs. Operated in approximately 30 countries, its shares are listed on the Shenzhen Stock Exchange.
